Skip to content
Screener

Kestra Medical Technologies KMTS Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$185.56B-24.8%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$3.73B-20.2%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$727.23M+5.1%
Haemonetics logo
HaemoneticsHAE
$4.36B-1.9%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Calculated from Kestra Medical Technologies’s reported figures.

$1.2Bmarket cap+$46.8Mtotal debt−$99.7Mcash and equivalents=$1.16B

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026. Open the filing →

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397

FAQ

What is Kestra Medical Technologies's enterprise value?
Kestra Medical Technologies (KMTS) reported enterprise value of $1.16B in Q1 2026.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Kestra Medical Technologies's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude